Thomas Hallam, outgoing Palisade Bio CEO
October 11, 2022 10:17 AM EDT
People

An­oth­er biotech CEO de­parts, leav­ing be­hind few em­ploy­ees for PhI­II

Kyle LaHucik

Senior Reporter

A month af­ter lay­ing off 20% of its em­ploy­ees, Pal­isade Bio’s CEO is al­so out the door. Thomas Hal­lam hit the ex­it on Mon­day and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times